Cambrian BioPharma Inc - 25 Feb 2022 Form 4 Insider Report for Sensei Biotherapeutics, Inc. (SNSE)

Role
10%+ Owner
Signature
Cambrian BioPharma Inc, by: /s/ James Peyer
Issuer symbol
SNSE
Transactions as of
25 Feb 2022
Transactions value $
$9,125
Form type
4
Filing time
28 Feb 2022, 15:50:45 UTC
Previous filing
24 Feb 2022
Next filing
01 Mar 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SNSE Common Stock Purchase $9.13K +2.5K +0.05% $3.65 5.23M 25 Feb 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares are held by Cambrian Biopharma, Inc., a Delaware corporation ("Cambrian"). The Chief Executive Officer of Cambrian, James Peyer, may direct the voting and disposition of the shares held by Cambrian, subject in certain instances to the approval of Cambrian's Board of Directors. Mr. Peyer disclaims beneficial ownership of such shares.